No need to overdo it with sunbathing to get some much needed vitamin D. According to a new study, the intake of probiotic supplements significantly improved levels of the vitamin in the body by 25%.
 
This is the first ever evidence that probiotics play an important role in maintaining and strengthening the bones.

Previous studies have established the effect of a specific probiotic strain Lactobacillus reuteri NCIMB 30242, which has a beneficial effect in reducing cholesterol levels, but its effect on the absorption of fat-soluble vitamins, vitamin D is unknown.

Researchers examine health data of a group of middle-aged volunteers who took probiotics for nine weeks.

They analyze the vitamin D levels by monitoring the levels of 25-hydroxyvitamin D in the blood.
 
The results show that taking probiotics has significantly increased the levels of the vitamin.
 
This is an important finding since mass is deficient in vitamin D, the researchers explain. Vitamin D deficiency is associated with osteoporosis and rickets in children. Lack of vitamin restricted absorption of calcium from the bones.

The 25-Hydroxyvitamin D Total ELISA is powered by unique monoclonal antibodies that express 100 % reactivity against 25 OH Vitamin D3 and 83% reactivity against 25OH Vitamin D2.
All In One technology. No extraction step, displacement solution directly into the well. Results in less than 4 hours. Calibrated against ID-LC/MS-MS (reference method). Bar codes on all components.

Technical spec.:

Downloads:

Protocol comparison with ELISA

INTENDED USE
The CA15-3 for the quantitative determination of the Cancer Antigen CA15-3 concentration in human serum. This kit is intended for research use only.

SUMMARY AND EXPLANATION
Breast cancer is the most common life-threatening malignant lesion in women of many developed countries today, with approximately 180,000 new cases diagnosed every year. Roughly half of these newly diagnosed patients are node-negative, however 30% of these cases progress to metastatic disease.
There are a number of tumor markers that can help clinicians to identify and diagnose which breast cancer patients will have aggressive disease and which will have an indolent course. These markers include estrogen and progesterone receptors, DNA ploidy and percent-S phase profile, epidermal growth factor receptor, HER-2/neu oncogene, p53 tumor suppressor gene, cathepsin D, proliferation markers and CA15-3. CA15-3 is most useful for monitoring patients post-operatively for recurrence, particularly metastatic
diseases. 96% of patients with local and systemic recurrence have elevated CA15-3, which can be used to predict recurrence earlier than radiological and clinical criteria. A 25% increase in the serum CA15-3 is associated with progression of carcinoma. A 50% decrease in serum CA15-3 is associated with response to treatment. CA15-3 is more sensitive than CEA in early detection of breast cancer recurrence. In combination with CA125, CA15-3 has been shown to be useful in early detection of relapse of ovarian
cancer. CA15-3 levels are also increased in colon, lung and hepatic tumors.

PRINCIPLE OF THE TEST
The CA15-3 ELISA test is based on the principle of a solid phase enzyme-linked immunosorbent assay. The assay system utilizes a monoclonal antibody directed against a distinct antigenic determinant on the intact CA15-3 molecule is used for solid phase immobilization (on the microtiter wells). A rabbit anti-CA15-3 antibody conjugated to horseradish peroxidase (HRPO) is in the antibody-enzyme conjugate solution. The test sample is allowed to react sequentially with the two antibodies, resulting in the CA15-3 molecules being sandwiched between the solid phase and enzyme-linked antibodies. After two separate 1-hour incubation steps at 37C, the wells are washed with water to remove unbound labeled antibodies. A solution of TMB Reagent is added and incubated for 20 minutes, resulting in the development of a blue color. The color development is stopped with the addition of Stop Solution changing the color to yellow. The concentration of CA15-3 is directly proportional to the color intensity of the test sample. Absorbance is measured spectrophotometrically at 450 nm.

Download PDF

Catalog number : YK090-SP
Quantity: 96well

Product Overview:
Glucagon is the most important counter-regulatory hormone to insulin in blood glucose homeostasis. It elevates blood glucose levels by stimulating gluconeogenesis and glycogenolysis while inhibiting glycogenesis and gylcolysis in the liver. This hormone is extremely important in studying therapeutic targets for diabetes, particularly Type I.
Background Information:
This assay is a chemiluminescent sandwich ELISA and is based on the capture of glucagon molecules in the sample, after extraction and reconstitution. This kit specifically measures intact glucagon, which is unique to many commercially available assays.
Usage Statement:
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Linearity of Dilution:
Contact Technical Service for this information
Sensitivity:
.003 ng/mL

Accuracy:
101%
Detection Methods:
Chemiluminescence
Cross Reactivity:
Refer to kit protocol for details
Product Name:
Glucagon ELISA Kit, Chemiluminescent
Standard Curve Range:
0.02 - 2 ng/mL
Specificity:
Glucagon (Human, Mouse, Rat and Porcine) 100%
Oxyntomodulin (Human, Mouse and Rat) <5%
Glucagon (1-18) 0%
Glucagon 19-29 (mini Glucagon) 0%
Analytes Available:
Glucagon

 Price: 741 EUR

Eine Krankenschwester von einem Krankenhaus, das Frankreichs einzigen bestätigten Fall des SARS ähnlichen Coronavirus der bereits 18 Menschen getötet hat gab selbst zu möglicherweise selber infiziert zu sein, sagte die Französiche Gesundheitsbehörde am Freitag.

Die Weltgesundheitsorganisation (WHO) erhöhte die Zahl der bestätigten Fälle Weltweit zu 33 nachdem Saudi Arabien sagte, dass zwei Menschen die ins Krankenhaus eingeliefert wurden dort im April durch Laboranalyse bestimmt worden waren mit dem Virus infiziert zu sein…

Lesen Sie die ganze Geschichte HIER.

Nicht zuletzt ist die Entstehung eines neuartigen Coronavirus (nCoV)eine wietere Bedrohung von neuen Viren der wir bevorstehen. Da viele von diesen Viren mit dem Menschen von wilden Tieren überqueren, weil Menschen immer tiefer und tiefer in den natürlichen Lebensraum von vielen Kreaturen reingraben. Und wir leben in einer Zeit, wo jeder neue Virus weniger als 24 Stunden von überall auf der Erde entfernt ist.

GENTAUR biete Ihnen eine Vielzahl von RT-PCR Assays, ELISA Kits, cDNAs und anderen molekularen Reagenzien, die uns helfen eine schnelle Antwort auf alle diese kommenden Bedrohungen zu finden.

*ELISA Kits

DEIA1035SARS Coronavirus IgG ELISA Kit - 1912 EUR

DEIA1036SARS Coronavirus IgM ELISA Kit - 1912 EUR

DEIA1035/DEIA1036: Dieses Kit verwendet eine feste Phase, indirekte ELISA assay zum Nachweis von IgG/IgM antikörper gegen SARS Coronavirus in zweistufigen Inkubations Verfahren. Mikrotiter Streifen warden vorher mit Coronavirus Antigenen gereinigt.

*Recombinante virale Antigene

- SARS-Assoziierte Coronavirus E recombinantes Antigen a.a. 1-76., #00191-v – 830 euro

- SARS-Assoziierte Coronavirus Nucleocapsid recombinanest Antigen N a.a. 1-49., #00192-v – 830 euro

- SARS-Assoziierte Coronavirus Nucleocapsid recombinantes Antigen C a.a. 340-390., #00193-v – 830 euro

- SARS-Assoziierte Coronavirus M recombinantes Antigen a.a. 182-216., #00194-v– 830 euro

-  SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S(N) a.a. 12-53/90-115/171-203., #00195-v – 830 euro

- SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S(M) a.a. 408-470/540-573., #00196-v – 830 euro

- SARS-Associated Coronavirus Spike mosaic recombinantes Antigen S© a.a. 1051-1076/1121-1154/1162-1190., #00197-v – 830 euro

Antikörper:

- Maus Monoklonal Anti-Mensch schweree akutes respiratorisches Syndrom (SARS-E2) Spezies Reactivität: menschlicher Coronavirus, #MA-20018,- 459 euro

- Maus Monoklonal Anti-Mensch schweres akutes respiratorosches Syndrom (SARS)-M Species Reactivity: menschlicher Coronavirus, # MA-20018, - 459 euro

- Anti-SARS Spitzenprotein IgG Spezies Reactivität: SARS, #AB-15710, - 433 euro

- Maus Anti-SARS Nucleocapsidprotein IgG Species Reactivität: MAUS, #AB-17810, - 498 euro

- Maus Anti-SARS Spike IgG Spezies Reactivität: MAUS, #AB-17910, - 498 euro

- Anti-SARS Nucleocapsidprotein IgG Spezies Reactivität: SARS, #AB-18010, - 498 euro

Recombinantes SARS-ACSM Antigen kann in ELISA und Western Blots verwendet werden, hervorragend für den Nachweis von SARS mit minimalen Spezifität Problemen!

SARS-ACSMS(M) (Reste 408-470, 540-573) SARS-Assoziiertes Coronavirus Spike Mosaic S(M)recombinant, E. Coli, #PR-1106, - 194 euro

SARS-ACSMS(C) (Reste 1051-1076, 1121-1154, 1162-1190) SARS-Assoziiertes Coronavirus Spike Mosaic S(C)recombinant, E. Coli, #PR-1105, -194 euro

SARS-ACN/3 (Reste 1-49, 192-220) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli, #PR-1104 - 194 euro

SARS-ACN/2 (Reste 1-49) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli, #PR-1103, - 194 euro

SARS-ACN/1 (Reste 340-390) SARS-Assoziiertes Coronavirus Nucleocapsid recombinant, E. Coli,PR-1102, - 194 euro

SARS-ACM (Reste 182-216) SARS-Assoziiertes Coronavirus Matrix rekombinant, E. Coli PR-1101,- 194 euro

SARS-ACE (Reste 1-76) SARS-Assoziiertes Coronavirus Umschlags rekombinant, E. Coli,PR-1100, - 194 euro

*Menschliches SARS cDNA Klon

Menschliches SARS cDNA klon, 10 g, Orf Größe: 1545, Vektor: pcDNA4/TO/myc-His A, # DC00346–  181 euro